From Stockholm to the World: Neko Health’s $260 Million Bet on the Future of Healthcare

Stockholm-based startup Neko Health is making waves in the healthcare industry with its bold vision of preventative care. And now, investors are doubling down on that vision. The company has just secured a whopping $260 million in Series B funding, catapulting its valuation to $1.8 billion. This isn’t just another funding round—it’s a seismic shift in how we think about healthcare.

“It’s very clear that there’s incredible demand for a different way of thinking about healthcare.”

Hjalmar Nilsonne, CEO and Co-Founder of Neko Health

Why Neko Health is a Game-Changer

Neko Health isn’t just another health tech startup. It’s a data-driven powerhouse that’s redefining preventative care. Here’s how:

• Proprietary Tech: Neko’s clinics use cutting-edge hardware and software to generate millions of health data points in just one hour.
• Comprehensive Diagnostics: From skin cancer detection to metabolic syndrome risk assessment, Neko covers it all.
• Global Expansion: With clinics in Stockholm and London, Neko is now eyeing the U.S. market, where demand is skyrocketing.

The Neko Experience: What You Get for £300

Imagine walking into a sleek, minimalist clinic where your health is analyzed down to the smallest detail. For £300, Neko offers:

• A full-body scan that detects moles, skin abnormalities, and more.
• Measurements of waist circumference, blood pressure, cholesterol, and heart rate.
• A consultation with a doctor and personalized follow-up recommendations.

And the best part? 80% of customers rebook for future appointments, proving that Neko’s approach isn’t just innovative—it’s addictive.

From Twitter DMs to a $1.8 Billion Valuation

Neko Health’s origin story is as unconventional as its approach to healthcare. Co-founders Hjalmar Nilsonne and Daniel Ek (yes, the Spotify founder) connected over Twitter in 2018. Neither had a background in healthcare, but their shared vision for preventative care sparked something extraordinary.

Fast forward six years, and Neko is now a vertically integrated healthcare juggernaut, designing its own devices, software, and clinics. As Nilsonne puts it, “The body scan today is kind of the iPod moment for Neko.”

What’s Next for Neko Health?

With $260 million in fresh funding, Neko is poised to dominate the preventative healthcare space. Here’s what’s on the horizon:

• U.S. Expansion: Neko is laying the groundwork for clinics in the U.S., where demand is already off the charts.
• R&D Investments: The company plans to enhance its hardware and software, adding more parameters and service tiers.
• Competitive Edge: Neko is pulling ahead of rivals like Zoi in France and Aware in Germany, as well as public health services like the NHS Health Check.

Why Investors Are Flocking to Neko

Neko’s waitlist has ballooned to over 100,000 people, and some of the most eager sign-ups are investors themselves. Lightspeed Venture Partners, the lead investor in this round, has already secured a seat on Neko’s board. As Nilsonne puts it, this funding will allow Neko to “double down and really increase our investments in making the product better.”

The Bottom Line

Neko Health isn’t just a startup—it’s a movement. By combining cutting-edge technology with a preventative care model, Neko is tackling some of the biggest challenges in healthcare. And with $260 million in funding, the company is just getting started. The future of healthcare is here, and it’s called Neko Health.